There’s no doubt about Cannabis’ psychoactive properties, but what is it that truly brings out that “high” among its users? Well, the answer is simple: Tetrahydrocannabinol or THC for short. This substance is a form of cannabidiol oil from among the hundreds of different forms of cannabinoids. Naturally, the amount of THC that can be contained within any food or beauty products has been limited by the FDA.
The Studies on Cannabinoids
According to a paper published by Molecules, amongst many different kinds of cannabinoids, Cannabidiol Oil or CBD, by itself, poses no health risks or psychoactive properties. However, many other of the components in Hemp and Cannabis does work as a stimulant and a psychoactive drug, which makes it difficult to incorporate CBD into food products without adding in some of the negative effects within it.
Further research shows that CBD might actually have benefits that NIDA actually wants to endorse in order to find better medicinal alternatives. For that specific reason, it’s difficult to actively discount the use of CBD in food and beauty products despite the possible harmful effects of it for the human body.
The FDA and THC Limitations
Since the worst of the Cannabinoids is the THC, The Food and Drug Administration of America has limited the use of THC in any kind of food or beauty products to be less than 0.3%. This is to ensure that no harmful doses of THC can be found from the ingestion or the use of these products while incorporating CBD into them.
Unfortunately, these “doses” are not properly monitored and tested by any government agencies to ensure the THC limit and that it doesn’t cause any “high”s in its users, let alone prevent them from failing a drug test.
Effects of Negligence
We’re not claiming that all of these products are inherently evil, as there have been some extraordinary successes in creating topical products beauty products with medicinal properties. Furthermore, with the advent of newer technology, we can expect to see a lot more of such beneficial products in the market.
Despite all that, the lack of proper monitoring is leading to many of the users of these said beauty and health products with more harm than good. Negligence in testing these products properly is leading harmful products to reach the shelves of even the largest of Pharmacies like CVS. To make matters worse, the use of these products are increasing their popularities, influencing other nations following our pop culture, making them invest more and more into these beauty products.
So, it is our earnest request to the proper authorities and channels to take good care of your own laws and do text all the products out in the market properly before deciding to allow them to be openly available at every gas stations and pharmacies without proper administration. Doing so will not only help the unfortunate users of these products who are unknowingly harming themselves but also reduce the amount of negativity and skepticism that CBD sees in the process.
US Navy Warns Their Sailors Not to Take CBD
Marines and sailors were told by the US Navy to stop and avoid using CBD and other hemp-derived products.
The US Navy legislation includes a clause that forbids servicepeople from using, ingesting, consuming and applying any cannabinoid preparation that is derived from marijuana or hemp.
Despite the legislation signed by President Donald Trump that removes industrial hemp from the controlled substances list of the federal government, Navy officials still affirm that their members should avoid hemp extracts and CBD products.
There is still a lot of controversy regarding CBD and its legality in the US. The Farm Bill signed last December has made most cannabidiol-containing products legal, although the FDA or Food and Drug Administration has reiterated that CBD-infused food is still illegal in the US.
Navy CBD Ban
A spokesperson for the US Navy stated that the Agriculture Improvement Act of 2018 has not affected in any way the policies of their agency. Despite the law, every product that is derived or made from marijuana or hemp are still very much prohibited.
The Navy stated that hemp-derived products that are commercially available like the CBD oil are not FDA-approved and therefore have no valid claims regarding the diagnosis, treatment, prevention or cure of any illness. They concluded that since the products do not properly list all their ingredients, it is impossible to determine the cannabidiol, THC or other synthetic cannabinoid levels such products may contain.
The agency defines Use as taking any cannabis preparation whether orally ingested, injected intravenously, vaporized/smoked or any other form by which such hemp-derived items may be introduced to the body, which potentially exposes the individual to high psychoactive THC levels.
Risk for Discharge
Navy servicepeople who show positive results for THC tests and other substances that are not prescribed by their doctor could be subject for discharge known as OTH or Other Than Honorable. This label can affect their employment opportunities and benefits as future veterans.
The Navy spokesperson added that every Sailor is responsible for ensuring their diligence in evading accidental or intentional contact with THC or any other controlled substance.
Just last month, police watchdogs from Arizona Peace Officer Standards and Training Board or AZPOST ruled that Arizona cops are allowed to use CBD and hemp-related products.
AZPOST stated on their ruling that the possession or use of over-the-counter CBD-containing products is not related to the illegal possession or use of marijuana, which is a dangerous narcotic drug.
In a report by the Pheonix New Times, it is in AZPOST’s history that OTC CBD use is regarded with the same treatment as in cannabis from a medical dispensary.
In Arizona, cannabis is lawful if used medically, but illegal for recreational purposes.
Lawmakers Pen Letter to Federal Agencies in Light of Growing CBD Industry
A group of US lawmakers addressed a letter to the Department of Health and Human Services or HHS and the Food and Drug Administration heads earlier this week to push for the establishment of regulations for CBD. This is in light of the cannabidiol industry showing great economic potential.
The group led by NY Democrat Rep. Antonio Delgado stated that the potential for a bigger market can affect the pharmaceuticals, paper, textiles, dietary supplements, and other products. Now that hemp and hemp-derived products like cannabidiol are now federally legal following the 2018 Farm Bill.
Delgado, also a member of the House Committee on Small Business, reiterated that the CBD industry also paves way for more employment opportunities and better local economies as more small firms lead the movement.
A hearing was heard by the panel last month to answer the challenges and opportunities for hemp enterprises regarding the federal prohibition framework.
Alongside Delgado are Committee Chairman Nydia Velasquez (Democrat, NY), Rep. Jared Golden (Democrat, ME), Rep. Adriano Espaillat (Democrat, NY) and Rep. Dwight Evans (Democrat, PA) who have all signed the message as well. Velasquez introduced another legislation earlier this week that provides insurance coverage for marijuana businesses.
What Lawmakers Wrote
The group collectively signed a letter that said the country’s farmers are looking forward to growing hemp and are awaiting the federal regulatory framework from the US Department of Agriculture. They also stated that businesses are gearing up on responding to consumer demands for hemp and its derivatives like CBD. However, the failure to clarify rules by the FDA confused businesses, consumers and farmers alike.
Ever since the passage of Farm Bill, the FDA and USDA have encountered pressure by different sectors to establish clear regulations. Last month, FDA said a status update will be released after the rulemaking process is fully expedited.
USDA, on the other hand, released a statement that said legal hemp regulations for cultivation will be given out before the planting season for 2020.
Lawmakers further added that the confusion regarding hemp regulation is hindering the growth and development of CBD businesses.
Scott Gottlieb, the former FDA commissioner, said that it may take years for CBD to be allowed in food or dietary supplements without congressional intervention. However, the group has declared that these products are already openly sold in commercial stores, pharmacies, restaurants and other places.
Pushing for More Clarity
The group of lawmakers also said that proper regulations will address the confusion on production, quality, labeling, testing, sale and marketing of hemp derivatives like CBD.
While the letter indicates that the group is appreciative of FDA’s efforts to ensure the public’s safety and guard them against unproven claims of other CBD companies, the hemp industry can’t take years of waiting for the agencies to create policies.
They further requested the FDA to develop benchmark quality standards for hemp and hemp derivatives production to harbor trust and satisfaction from consumers so that the industry can mature into a lawful market.
The FDA is expected by the group to release enforcement guidance and interim final ruling on CBD-infused food and dietary supplements by September 30. This is to pave way for a final and legal rule for such products, especially since the Federal government has recognized the hemp industry, and medical marijuana for some states as legal substances.
CBD Oil Brand Recalled for High THC Level by Irish Government
Dutch cannabinoid oil (CBD) brand EUPHORIA was found to have illegal levels of Tetrahydrocannabinol (THC) in the formulation, causing the Food Safety Authority of Ireland (FSAI) to recall their 10ml preparation labeled “Full Spectrum Oil extra strong 20%”.
Hemp and CBD products are legal as per the regulation of the Irish government; however, the formula should not contain THC of more than 0.2% to be viable for sale.
Said oil brand came from the Netherlands and has a best-before date of 31 August in 2020. Distributors and retailers alike are forced to submit to authority and remove the brand from their displays immediately.
CBD is gaining popularity all over the world and is a steadily growing industry due to respective laws being legislated in a number of countries. However, controversy still can’t escape it since it is closely linked to marijuana and THC, which have potent psychoactive elements that can induce drug dependency.
Cannabis Reception in Ireland
In Ireland, cannabis is still a huge topic for debate for supporters and critics. Some people still doubt its efficacy and the presence of side effects that may prove dangerous for a person’s health. The question mark that follows cannabis is heightened because of this recent turn of events.
The country authorized the sale and use of medical cannabis last 2016, but it was met with opposition from a group of medical practitioners. It’s also a hard feat for patients to acquire such since the government failed to retain a central supplier.
To reconcile their lack in implementation, the Ministry of Health headed by Simon Harris recently signed into legislation the 5-year Medical Cannabis Access Program. It aims to push for cannabis treatment when traditional methods fail, according to Harris.
This initiative is designed to legalize medical cannabis prescription made by doctors for various conditions like chemotherapy-sickness, epilepsy, and multiple sclerosis. Like any pharmaceutical product, patients can now present their Rx to drug stores and be given said medicine.
The program also involves the inventory-building of cannabis products, with Tilray being one of the international cannabis companies to successfully export their medical cannabis products to Ireland.
In relation to their first shipment, Tilray has pledged its commitment to providing for the subsequent demands of cannabis products once approved by the government. Their goal is to be the main supplier of the access program, enabling safe and reasonable access to medical cannabis
The company is currently at dialogue with the Irish authorities to shed some insight on the implementation of the newly penned program.
Unfortunately, Tilray failed to secure a spot in Italian cannabis export.
Cannabis in Neighboring Italy
Italy snubbed Tilray and two other international cannabis companies in favor of Aurora Cannabis (Canada) to fulfill the surprising shortage in production at the Florence facility. Italian Ministry of Defense further revealed that Tilray (Portugal) filed incorrect paper works and missed the set deadline, disqualifying them from the roster.
Albeit Italy’s willingness to pay for medical cannabis (the 400-kg cannabis deal cost them €569,000 (US$638,000), debates are also going over the country on whether low-THC “cannabis light” should be sold legally. The court ruled to ban the sale of such products, but enterprise owners fought back.
While it might be a phenomenal story to follow, Italians still appreciate cannabis products such as the CBD oil as an adjunct to medical treatments. Italy, including the Netherlands and Germany, are still the top three European countries with the strong medicinal cannabis industry.
Featured7 months ago
Benefits of CBD Oil for Dogs You Might Not Know About
Research8 months ago
Does CBD Oil Have Side Effects? Studies Say Yes, It Does
Featured8 months ago
What is CBD and it’s Health Benefits?
Research6 months ago
CBD Oil Can Help you Sleep [According to the latest Study]
Featured9 months ago
Upcoming Cannabis Trends in 2019
Featured5 months ago
Is Golf Pro Phil Mickelson Resorting To CBD Oil For Fighting Arthritis?
Featured1 month ago
Surprise Discovery: Mother Finds 4x THC Legal Limit in CBD Oil for Anxiety, Other Varieties Don’t Have Cannabidiol
Regulations4 months ago
Europe To Increase The Thc Limit: New Hope For Hemp Farmers